USEUROPEAFRICAASIA 中文双语Français
Business
Home / Business / Policy Watch

China to regulate TCM market

Xinhua | Updated: 2013-07-31 09:16

BEIJING - The China Food and Drug Administration (CFDA) on Tuesday called on medical ingredient markets nationwide to curb the manufacture and sale of counterfeit traditional Chinese medicine (TCM).

Officials in charge of TCM trade centers in 17 cities were summoned to a CFDA meeting on regulating the market.

During CFDA's recent inspections of the TCM market, it found that the production and sale of counterfeit medicine, as well as illegal processing and business operations, are occurring in the medical ingredient market, according to a statement from the administration.

"Firm determination should be used to rectify the market," said CFDA deputy director Wu Zhen.

The move is part of a national campaign starting from July 17 to crack down on counterfeit medicine.

Problematic medical ingredient centers should be closed, criminals should be seriously punished and relevant officials should be held accountable, said Wu.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US